相似文献
1
Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma.
Proc Natl Acad Sci U S A. 1976 Nov;73(11):4179-83. doi: 10.1073/pnas.73.11.4179.
2
Interactions among Hageman factor, plasma prekallikrein, high molecular weight kininogen, and plasma thromboplastin antecedent.
Proc Natl Acad Sci U S A. 1979 Feb;76(2):958-61. doi: 10.1073/pnas.76.2.958.
3
The role of bovine high-molecular-weight (HMW) kininogen in contact-mediated activation of bovine factor XII: interaction of HMW kininogen with kaolin and plasma prekallikrein.
J Biochem. 1981 Jun;89(6):1699-709. doi: 10.1093/oxfordjournals.jbchem.a133370.
4
Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor.
Proc Natl Acad Sci U S A. 1976 Aug;73(8):2554-8. doi: 10.1073/pnas.73.8.2554.
5
Role of high-molecular-weight kininogen in surface-binding and activation of coagulation Factor XI and prekallikrein.
Proc Natl Acad Sci U S A. 1977 Oct;74(10):4636-40. doi: 10.1073/pnas.74.10.4636.
6
Interaction of factor XII, high-molecular-weight (HMW) kininogen and prekallikrein with sulfatide: analysis by fluorescence polarization.
J Biochem. 1985 Jun;97(6):1637-44. doi: 10.1093/oxfordjournals.jbchem.a135221.
7
Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.
J Clin Invest. 1984 Apr;73(4):954-62. doi: 10.1172/JCI111319.
8
Kinetic studies on surface-mediated activation of bovine factor XII and prekallikrein. Effects of kaolin and high-Mr kininogen on the activation reactions.
Eur J Biochem. 1985 Jan 2;146(1):43-50. doi: 10.1111/j.1432-1033.1985.tb08617.x.
9
The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen.
J Clin Invest. 1977 Jun;59(6):1167-75. doi: 10.1172/JCI108741.
10
Activation of surface-bound Hageman factor: pre-eminent role of high molecular weight kininogen and evidence for a new factor.
Adv Exp Med Biol. 1976;70(00):285-99. doi: 10.1007/978-1-4684-3267-1_35.
引用本文的文献
1
Alzheimer's Disease: In Vitro and In Vivo Evidence of Activation of the Plasma Bradykinin-Forming Cascade and Implications for Therapy.
Cells. 2024 Dec 10;13(24):2039. doi: 10.3390/cells13242039.
2
Discovery of α-Amidobenzylboronates as Highly Potent Covalent Inhibitors of Plasma Kallikrein.
ACS Med Chem Lett. 2024 Mar 28;15(4):501-509. doi: 10.1021/acsmedchemlett.3c00572. eCollection 2024 Apr 11.
3
High molecular weight kininogen interactions with the homologs prekallikrein and factor XI: importance to surface-induced coagulation.
J Thromb Haemost. 2024 Jan;22(1):225-237. doi: 10.1016/j.jtha.2023.09.027. Epub 2023 Oct 9.
4
Human plasma kallikrein: roles in coagulation, fibrinolysis, inflammation pathways, and beyond.
Front Physiol. 2023 Aug 30;14:1188816. doi: 10.3389/fphys.2023.1188816. eCollection 2023.
5
Population serum proteomics uncovers a prognostic protein classifier for metabolic syndrome.
Cell Rep Med. 2023 Sep 19;4(9):101172. doi: 10.1016/j.xcrm.2023.101172. Epub 2023 Aug 30.
6
A possible mechanism for the enhanced toxicity of beta-amyloid protofibrils in Alzheimer's disease.
Proc Natl Acad Sci U S A. 2023 Sep 5;120(36):e2309389120. doi: 10.1073/pnas.2309389120. Epub 2023 Aug 28.
7
Mechanisms involved in hereditary angioedema with normal C1-inhibitor activity.
Front Physiol. 2023 May 23;14:1146834. doi: 10.3389/fphys.2023.1146834. eCollection 2023.
8
Anti-HK antibody inhibits the plasma contact system by blocking prekallikrein and factor XI activation in vivo.
Blood Adv. 2023 Apr 11;7(7):1156-1167. doi: 10.1182/bloodadvances.2021006485.
9
Blocking domain 6 of high molecular weight kininogen to understand intrinsic clotting mechanisms.
Res Pract Thromb Haemost. 2022 Oct 13;6(7):e12815. doi: 10.1002/rth2.12815. eCollection 2022 Oct.
10
The complex role of kininogens in hereditary angioedema.
Front Allergy. 2022 Aug 3;3:952753. doi: 10.3389/falgy.2022.952753. eCollection 2022.
本文引用的文献
1
Fitzgerald Trait: Deficiency of a Hitherto Unrecognized Agent, Fitzgerald Factor, Participating in Surface-Mediated Reactions of Clotting, Fibrinolysis, Generation of Kinins, and the Property of Diluted Plasma Enhancing Vascular Permeability (PF/Dil).
J Clin Invest. 1975 May;55(5):1082-9. doi: 10.1172/JCI108009.
2
Protein measurement with the Folin phenol reagent.
J Biol Chem. 1951 Nov;193(1):265-75.
3
THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.
Biochem J. 1963 Oct;89(1):114-23. doi: 10.1042/bj0890114.
4
The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies.
Am J Clin Pathol. 1961 Sep;36:212-9. doi: 10.1093/ajcp/36.3.212.
5
Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.
J Clin Invest. 1974 Feb;53(2):622-33. doi: 10.1172/JCI107597.
6
Chemical coupling of peptides and proteins to polysaccharides by means of cyanogen halides.
Nature. 1967 Jun 24;214(5095):1302-4. doi: 10.1038/2141302a0.
7
The gel-filtration behaviour of proteins related to their molecular weights over a wide range.
Biochem J. 1965 Sep;96(3):595-606. doi: 10.1042/bj0960595.
8
The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.
J Biol Chem. 1969 Aug 25;244(16):4406-12.
9
A pre-albumin activator of prekallikrein.
J Immunol. 1970 Oct;105(4):802-11.
10
A prealbumin activator of prekallikrein. 3. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein.
J Exp Med. 1972 Jan;135(1):81-97. doi: 10.1084/jem.135.1.81.
Zotero 插件